Association of Obesity Paradox with Prognosis of Veno-venous-extracorporeal Membrane Oxygenation in Patients with Coronavirus Disease 2019

Overview

Journal Acute Med Surg

Specialty Critical Care

Date 2023 Jul 20

PMID 37469378

Authors

Hiroshi Honzawa

Hayato Taniguchi

Fumihiro Ogawa

Yasufumi Oi

Takeru Abe

Ichiro Takeuchi

Affiliations

Soon will be listed here.

Abstract

Aim: Although the obesity paradox is known for various diseases, including cancer and acute respiratory distress syndrome, little is known about veno-venous extracorporeal membrane oxygenation (VV-ECMO) in patients with coronavirus disease 2019 (COVID-19). In this study, we aimed to investigate the association between body mass index (BMI) and prognosis in critical patients with COVID-19 requiring VV-ECMO.

Methods: We conducted a retrospective observational single-center study at Yokohama City University Civic General Medical Center between March 2020 and October 2021. Participants were patients with COVID-19 who required VV-ECMO. They were classified into two groups: BMI ≤30 kg/m and >30 kg/m.

Results: In total, 23 patients were included in the analysis, with a median BMI of 28.7 kg/m. Overall, 22 patients were successfully weaned from the ECMO. When comparing the two groups, there was a trend toward fewer days from onset to ECMO induction in the BMI >30 kg/m group. Moreover, the two groups had a similar prognosis. There were no statistically significant differences in the number of days from onset to hospitalization or the duration of ECMO induction between the groups.

Conclusion: VV-ECMO induction for patients with COVID-19 may lead to earlier indications in patients with BMI >30 kg/m than in those with BMI ≤30 kg/m.

Citing Articles

Specific and Non-specific Aspects and Future Challenges of ICU Care Among COVID-19 Patients with Obesity: A Narrative Review.

Beurton A, Kooistra E, De Jong A, Schiffl H, Jourdain M, Garcia B Curr Obes Rep. 2024; 13(3):545-563.

PMID: 38573465 DOI: 10.1007/s13679-024-00562-3.

Association of obesity paradox with prognosis of veno-venous-extracorporeal membrane oxygenation in patients with coronavirus disease 2019.

Honzawa H, Taniguchi H, Ogawa F, Oi Y, Abe T, Takeuchi I Acute Med Surg. 2023; 10(1):e871.

PMID: 37469378 PMC: 10352545. DOI: 10.1002/ams2.871.

References

Bein T . Driving pressure in obese ventilated patients: another brick in the (chest) wall. Intensive Care Med. 2018; 44(8):1349-1351. DOI: 10.1007/s00134-018-5288-4. View

Mongero L, Stammers A, Tesdahl E, Petersen C, Patel K, Jacobs J . The Use of Extracorporeal Membrane Oxygenation in COVID-19 Patients with Severe Cardiorespiratory Failure: The Influence of Obesity on Outcomes. J Extra Corpor Technol. 2022; 53(4):293-298. PMC: 8717732. DOI: 10.1182/ject-2100034. View

LADOSKY W, Botelho M, Albuquerque Jr J . Chest mechanics in morbidly obese non-hypoventilated patients. Respir Med. 2001; 95(4):281-6. DOI: 10.1053/rmed.2001.1035. View

Honzawa H, Taniguchi H, Ogawa F, Oi Y, Abe T, Takeuchi I . Association of obesity paradox with prognosis of veno-venous-extracorporeal membrane oxygenation in patients with coronavirus disease 2019. Acute Med Surg. 2023; 10(1):e871. PMC: 10352545. DOI: 10.1002/ams2.871. View

Zhou D, Wang C, Lin Q, Li T . The obesity paradox for survivors of critically ill patients. Crit Care. 2022; 26(1):198. PMC: 9251913. DOI: 10.1186/s13054-022-04074-1. View

Amato M, Meade M, Slutsky A, Brochard L, Costa E, Schoenfeld D . Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med. 2015; 372(8):747-55. DOI: 10.1056/NEJMsa1410639. View

Littleton S . Impact of obesity on respiratory function. Respirology. 2011; 17(1):43-9. DOI: 10.1111/j.1440-1843.2011.02096.x. View

Barbaro R, MacLaren G, Boonstra P, Combes A, Agerstrand C, Annich G . Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry. Lancet. 2021; 398(10307):1230-1238. PMC: 8480964. DOI: 10.1016/S0140-6736(21)01960-7. View

Peek G, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany M . Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009; 374(9698):1351-63. DOI: 10.1016/S0140-6736(09)61069-2. View

10.

Daviet F, Guilloux P, Hraiech S, Tonon D, Velly L, Bourenne J . Impact of obesity on survival in COVID-19 ARDS patients receiving ECMO: results from an ambispective observational cohort. Ann Intensive Care. 2021; 11(1):157. PMC: 8591429. DOI: 10.1186/s13613-021-00943-0. View

11.

Chommeloux J, Valentin S, Winiszewski H, Adda M, De Chambrun M, Moyon Q . One-Year Mental and Physical Health Assessment in Survivors after Extracorporeal Membrane Oxygenation for COVID-19-related Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2022; 207(2):150-159. PMC: 9893333. DOI: 10.1164/rccm.202206-1145OC. View

12.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

13.

Schavemaker R, Schultz M, Lagrand W, van Slobbe-Bijlsma E, Serpa Neto A, Paulus F . Associations of Body Mass Index with Ventilation Management and Clinical Outcomes in Invasively Ventilated Patients with ARDS Related to COVID-19-Insights from the PRoVENT-COVID Study. J Clin Med. 2021; 10(6). PMC: 8000207. DOI: 10.3390/jcm10061176. View

14.

Stapleton R, Dixon A, Parsons P, Ware L, Suratt B . The association between BMI and plasma cytokine levels in patients with acute lung injury. Chest. 2010; 138(3):568-77. PMC: 2940070. DOI: 10.1378/chest.10-0014. View

15.

Wang R, Sun B, Li X, Tang X, He H, Li Y . Mechanical Ventilation Strategy Guided by Transpulmonary Pressure in Severe Acute Respiratory Distress Syndrome Treated With Venovenous Extracorporeal Membrane Oxygenation. Crit Care Med. 2020; 48(9):1280-1288. DOI: 10.1097/CCM.0000000000004445. View

16.

Horwich T, Fonarow G, Clark A . Obesity and the Obesity Paradox in Heart Failure. Prog Cardiovasc Dis. 2018; 61(2):151-156. DOI: 10.1016/j.pcad.2018.05.005. View

17.

Schetz M, De Jong A, Deane A, Druml W, Hemelaar P, Pelosi P . Obesity in the critically ill: a narrative review. Intensive Care Med. 2019; 45(6):757-769. DOI: 10.1007/s00134-019-05594-1. View

18.

Shaefi S, Brenner S, Gupta S, OGara B, Krajewski M, Charytan D . Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19. Intensive Care Med. 2021; 47(2):208-221. PMC: 7851810. DOI: 10.1007/s00134-020-06331-9. View

19.

Cho W, Oh J, Yeo H, Han J, Kim J, Hong S . Obesity survival paradox in pneumonia supported with extracorporeal membrane oxygenation: Analysis of the national registry. J Crit Care. 2018; 48:453-457. DOI: 10.1016/j.jcrc.2018.08.003. View

20.

Gao Y, Ding M, Dong X, Zhang J, Azkur A, Azkur D . Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2020; 76(2):428-455. DOI: 10.1111/all.14657. View